Concepedia

Publication | Closed Access

Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction

DOI

205

Citations

27

References

2001

Year

Kenneth W. Baran, Michel Nguyen, George R. McKendall, Costas T. Lambrew, Gary Dykstra, Sebastian T. Palmeri, Raymond J. Gibbons, Steven Borzak, Burton E. Sobel, Steven G. Gourlay,
Circulation

Abstract

RhuMAb CD18 was well tolerated but not effective in modifying cardiac end points.

References

YearCitations

Page 1